產(chǎn)品名稱(chēng) MDL 201012
產(chǎn)品貨號(hào) Axon 1679 CAS [136722-45-7] MF C19H25NO2MW 299.41 Purity: 98% Soluble in DMSO Description Selective M3 muscarinic receptor antagonist; orally active antimuscarinic agent References Certificates Categories Extra info DL Reynolds et al. Determination of MDL 201,012 at femtomole/millilitre levels in human plasma by liquid chromatography with electrochemical detection.?Biomed Chromatogr. 1992, 6(6), 295-9. ? JP Carter et al. Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds. J. Med. Chem. 1991, 34(10), 3065-74. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS Diabetes & Metabolism CHRM3 A18 Muscarinic M3 antagonist Chemical name 1-cyclobutyl-7-(dimethylamino)-1-hydroxy-1-phenylhept-5-yn-2-one Parent CAS No. [136722-45-7] Order Size Unit Price Stock 10 mg €110.00 In Stock
產(chǎn)品價(jià)格 現(xiàn)貨詢(xún)價(jià),電話(huà):010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

MDL 201012

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1679

CAS [136722-45-7]

MF C19H25NO2
MW 299.41

  • Purity: 98%
  • Soluble in DMSO

MDL 201012

Description

Selective M3 muscarinic receptor antagonist; orally active antimuscarinic agent
產(chǎn)品資料